EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $217,654 | -5.0% | 7,672 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $229,134 | -99.9% | 7,839 | -49.4% | 0.00% | 0.0% |
| Q3 2022 | $205,205,000 | +59552.6% | 15,502 | +100.2% | 0.00% | -50.0% |
| Q2 2022 | $344,000 | -9.5% | 7,743 | +0.9% | 0.00% | 0.0% |
| Q1 2022 | $380,000 | -4.3% | 7,677 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $397,000 | -8.7% | 7,796 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $435,000 | +30.6% | 7,794 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $333,000 | +1.5% | 7,791 | -1.0% | 0.00% | 0.0% |
| Q1 2021 | $328,000 | -6.0% | 7,867 | +4.8% | 0.00% | 0.0% |
| Q4 2020 | $349,000 | -99.9% | 7,505 | +7047.6% | 0.00% | -33.3% |
| Q3 2020 | $310,000,000 | – | 105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |